PTK2 and adrenal cortex carcinoma: These are consistent with transcriptomic data from human ACC samples, where high FAK expression was associated with poorer progression-free and overall survival—supporting the role of FAK in promoting tumour progression through enhanced cell migration and metastatic potential.